Initially Unresectable Rectal Adenocarcinoma Treated with Preoperative Irradiation and Surgery
Overview
Affiliations
This is an analysis of 23 patients with clinically and/or surgically unresectable adenocarcinoma of the rectum on initial evaluation who were treated with preoperative irradiation and surgery between March 1970 and April 1981. All patients have had follow-up for at least 5 years. Five patients (22%) had exploratory laparotomy and diverting colostomy before irradiation. All patients were irradiated with megavoltage equipment to the pelvis at 180 rad/fraction, continuous-course technique. Total doses ranged from 3500 to 6000 rad with a mean of 4800 rad and a median of 5000 rad. All patients had surgery 2-11 weeks (mean: 4.9 weeks; median: 4 weeks) after radiation therapy. Twelve patients (52%) had lesions that were incompletely resected because of positive margins (7 patients), distant metastasis (1 patient), or both (4 patients). All of these patients died of cancer within 5 years of treatment. Eleven patients had an apparent complete excision of their rectal cancer; six patients (55%) subsequently had a local recurrence. The 5-year absolute survival rate for patients who had complete resection was 18% (2 of 11 patients). The 5-year absolute and determinate survival rates for the entire study were 9% (2 of 23 patients) and 9% (2 of 22 patients), respectively. One patient (in the incomplete resection group) died after operation secondary to sepsis and diffuse intravascular coagulation.
Terezakis S, Morikawa L, Wu A, Zhang Z, Shi W, Weiser M Ann Surg Oncol. 2015; 22(7):2168-78.
PMID: 25631062 PMC: 5316234. DOI: 10.1245/s10434-014-4271-8.
Lowy A, Rich T, Skibber J, Dubrow R, Curley S Ann Surg. 1996; 223(2):177-85.
PMID: 8597512 PMC: 1235094. DOI: 10.1097/00000658-199602000-00010.
Kraus T, Eble M, Raeth U Langenbecks Arch Chir. 1994; 379(6):353-7.
PMID: 7845161 DOI: 10.1007/BF00191582.
Lewis W, Williamson M, Kuzu A, Stephenson B, Holdsworth P, Finan P Int J Colorectal Dis. 1995; 10(3):133-7.
PMID: 7561428 DOI: 10.1007/BF00298533.
Is total pelvic exenteration reasonable primary treatment for rectal carcinoma?.
WILLIAMS Jr L, Huddleston C, SAWYERS J, Potts 3rd J, Sharp K, McDougal S Ann Surg. 1988; 207(6):670-8.
PMID: 3291792 PMC: 1493536. DOI: 10.1097/00000658-198806000-00005.